These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2517498)

  • 21. Defibrotide has antiischemic activity in perfused rabbit hearts, preventing tissue Ca++ overloading.
    Berti F; Rossoni G; Galli G; Magni F; Mantovani M; Calvani AB; Porta R; Prino G
    Thromb Res; 1992 Jan; 65(1):13-26. PubMed ID: 1604439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial protection by defibrotide--a new strategy for treatment of myocardial infarction?
    Schrör K; Ackermann G; Hohlfeld T; Löbel P; Ney P; Schröder H; Strobach H
    Z Kardiol; 1989; 78 Suppl 6():35-41. PubMed ID: 2559554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of prostacyclin on the cardiac functions and energy metabolism in the perfused rat heart].
    Takeuchi S
    Hokkaido Igaku Zasshi; 1985 May; 60(3):355-67. PubMed ID: 3894189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective activity of defibrotide against lethal acute myocardial ischemia in the cat.
    Niada R; Porta R; Pescador R; Mantovani M; Prino G
    Thromb Res; 1986 May; 42(3):363-74. PubMed ID: 3087010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved metabolic function of rat heart during procurement using defibrotide.
    Ferrero ME; Marni A; Aimini R; Bergamasco E; Gaja G
    Transplant Proc; 1990 Oct; 22(5):2230-2. PubMed ID: 2171166
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of the thromboxane synthetase inhibitor HOE 944, prostacyclin and indomethacin on reperfusion arrhythmias, cardiodynamics and metabolism in isolated ischemic rat hearts.
    Linz W; Lau HH; Beck G; Schökens BA
    Biomed Biochim Acta; 1988; 47(10-11):S23-6. PubMed ID: 3073762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of vascular prostacyclin and inhibition of platelet function by oral defibrotide in cholesterol-fed rabbits.
    Löbel P; Schrör K
    Atherosclerosis; 1989 Nov; 80(1):69-79. PubMed ID: 2513813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protective mechanisms of defibrotide on liver ischaemia-reperfusion injury.
    Aydemir EO; Var A; Uyanik BS; Ilkgül O; Aydede H; Sakarya A
    Cell Biochem Funct; 2003 Dec; 21(4):307-10. PubMed ID: 14624467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bradykinin improves postischaemic recovery in the rat heart: role of high energy phosphates, nitric oxide, and prostacyclin.
    Zhu P; Zaugg CE; Simper D; Hornstein P; Allegrini PR; Buser PT
    Cardiovasc Res; 1995 May; 29(5):658-63. PubMed ID: 7606754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel beneficial effects of defibrotide, an endothelium protecting agent, following ischemia and reperfusion in the isolated perfused rat heart.
    Shin YK; Campbell B; Lefer AM
    Methods Find Exp Clin Pharmacol; 1998; 20(6):463-71. PubMed ID: 9789870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of kidney from postischemic reperfusion injury in rats treated with defibrotide.
    Marni A; Ferrero ME; Rovati M; Salari PC; Gaja G
    Transplant Proc; 1990 Oct; 22(5):2226-9. PubMed ID: 2171165
    [No Abstract]   [Full Text] [Related]  

  • 32. Defibrotide, an antithrombotic substance that preserves postsynaptic alpha- and beta-adrenergic function in post acute infarcted rabbit hearts.
    Berti F; Rossoni G; Niada R; Folco G; Omini C; Tondo C
    J Cardiovasc Pharmacol; 1986; 8(2):235-40. PubMed ID: 2422459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amelioration of liver injury by ischaemic preconditioning.
    Yoshizumi T; Yanaga K; Soejima Y; Maeda T; Uchiyama H; Sugimachi K
    Br J Surg; 1998 Dec; 85(12):1636-40. PubMed ID: 9876065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is lactate-induced myocardial ischaemic injury mediated by decreased pH or increased intracellular lactate?
    Cross HR; Clarke K; Opie LH; Radda GK
    J Mol Cell Cardiol; 1995 Jul; 27(7):1369-81. PubMed ID: 7473783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by defibrotide in the platelet perfused heart.
    Löbel P; Schrör K
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):125-30. PubMed ID: 3937058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary venous drug infusion in the ischaemic-reperfused isolated rat heart.
    Uriuda Y; Wang QD; Li XS; Sjoquist PO; Nordlander R; Ryden L
    Cardiovasc Res; 1996 Jan; 31(1):82-92. PubMed ID: 8849592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
    Aoki N; Siegfried M; Tsao P; Lento P; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):275-89. PubMed ID: 3175328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of landiolol on mechanical and metabolic changes in rat reperfused ischaemic hearts.
    Sakanashi M; Sakanashi M; Sugahara K; Sakanashi M
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):55-60. PubMed ID: 17201736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production and biologic interactions of prostacyclin and platelet-activating factor in acute myocardial ischemia in the perfused rabbit heart.
    Berti F; Magni F; Rossoni G; De Angelis L; Galli G
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):727-32. PubMed ID: 1703593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardioprotective effects of defibrotide in acute lethal and nonlethal myocardial ischemia in the cat.
    Niada R; Porta R; Pescador R; Mantovani M; Prino G; Berti F
    Haemostasis; 1986; 16 Suppl 1():18-25. PubMed ID: 3519380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.